These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18485224)

  • 1. COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro.
    Chuang HC; Kardosh A; Gaffney KJ; Petasis NA; Schönthal AH
    Mol Cancer; 2008 May; 7():38. PubMed ID: 18485224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
    Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
    Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
    Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
    Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib.
    Kardosh A; Soriano N; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen TC; Schönthal AH
    Blood; 2005 Dec; 106(13):4330-8. PubMed ID: 16123214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.
    Kardosh A; Wang W; Uddin J; Petasis NA; Hofman FM; Chen TC; Schönthal AH
    Cancer Biol Ther; 2005 May; 4(5):571-82. PubMed ID: 15846081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
    Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
    Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W; Yu CH; Hu KQ
    Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
    Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
    Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
    Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
    Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2.
    Chen ST; Thomas S; Gaffney KJ; Louie SG; Petasis NA; Schönthal AH
    Leuk Res; 2010 Feb; 34(2):250-3. PubMed ID: 19833390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.
    Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW
    Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line.
    Nikanfar S; Atari-Hajipirloo S; Kheradmand F; Rashedi J; Heydari A
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):8-13. PubMed ID: 29974839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs.
    Schönthal AH; Chen TC; Hofman FM; Louie SG; Petasis NA
    Expert Opin Investig Drugs; 2008 Feb; 17(2):197-208. PubMed ID: 18230053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
    BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy.
    Schönthal AH
    Neurosurg Focus; 2006 Apr; 20(4):E21. PubMed ID: 16709027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells.
    Kulp SK; Yang YT; Hung CC; Chen KF; Lai JP; Tseng PH; Fowble JW; Ward PJ; Chen CS
    Cancer Res; 2004 Feb; 64(4):1444-51. PubMed ID: 14973075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.